A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects

Osteoporosis International

Volumn 25, Issue 8, 2014, Pages 2089-2096

  Wei, L ^a   Ke, J ^a   Prasadam, I ^c   Miron, R J ^a   Lin, S ^a   Xiao, Y ^c   Chang, J ^b   Wu, C ^b   Zhang, Y ^a  

^a Wuhan University   (China)

^b SHANGHAI INSTITUTE OF CERAMICS   (China)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Bioactive scaffolds; Estrogen; Osteoporotic bone; Strontium

Indexed keywords

MESOPOROUS BIOACTIVE GLASS SCAFFOLD; STRONTIUM; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; BIOGLASS; BONE DENSITY CONSERVATION AGENT; CERAMICS;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; BONE REGENERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; ESTROGEN THERAPY; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOPENIA; OVARIECTOMY; PRIORITY JOURNAL; RAT; TRABECULAR BONE; ANIMAL; BONE DISEASES, METABOLIC; CERAMICS; DRUG EFFECTS; FEMUR; INFUSION PUMP; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RADIOGRAPHY; TISSUE SCAFFOLD; WISTAR RAT;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; BONE REGENERATION; CERAMICS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR; INFUSION PUMPS, IMPLANTABLE; OSTEOGENESIS; OVARIECTOMY; RATS, WISTAR; STRONTIUM; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84904416301     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2735-0     Document Type: Article

References (33)

1. Fini M, Giavaresi G, Torricelli P, Borsari V, Giardino R, Nicolini A, Carpi A (2004) Osteoporosis and biomaterial osteointegration. Biomed Pharmacother 58:487-493 (Pubitemid 39423595)
2. Fini M, Carpi A, Borsari V, Tschon M, Nicolini A, Sartori M, Mechanick J, Giardino R (2010) Bone remodeling, humoral networks and smart biomaterial technology for osteoporosis. Front Biosci (Schol Ed) 2:468-482
3. Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C, Epidemiology IOFW Go, Quality of L (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239-2256
4. Catala-Lopez F, Sanfelix-Gimeno G, Tobias A, Hurtado I, Sanfelix-Genoves J, Peiro S (2013) Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis? Osteoporos Int 24:1927-1928
5. Zallone A (2006) Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N YAcad Sci 1068:173-179
6. Almeida M, Iyer S, Martin-Millan M et al (2013) Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest 123:394-404
7. Richette P, Roux C (2012) Impact of treatments for osteoporosis on cartilage biomarkers in humans. Osteoporos Int 23(Suppl 8):S877-S880
8. Roux C, Richette P (2012) Impact of treatments for osteoporosis on osteoarthritis progression. Osteoporos Int 23(Suppl 8):S881-S883
9. Maimoun L, Brennan TC, Badoud I, Dubois-Ferriere V, Rizzoli R, Ammann P (2010) Strontium ranelate improves implant osseointegration. Bone 46:1436-1441
10. Alegre DN, Ribeiro C, Sousa C, Correia J, Silva L, de Almeida L (2012) Possible benefits of strontium ranelate in complicated long bone fractures. Rheumatol Int 32:439-443
11. Hiligsmann M, Ben Sedrine W, Bruyere O, Reginster JY (2013) Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis. Osteoporos Int 24:2291-2300
12. Doublier A, Farlay D, Jaurand X, Vera R, Boivin G (2013) Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women. Osteoporos Int 24:1079-1087
13. Li Y, Feng G, Gao Y, Luo E, Liu X, Hu J (2010) Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res 28:578-582
14. Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res Off J Am Soc Bone Min Res 22:1419-1425 (Pubitemid 351339686)
15. Marie PJ (2006) Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol 18(Suppl 1):S11-S15
16. Kendler DL (2006) Strontium ranelate - data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action. Curr Osteoporos Rep 4:34-39
17. Yan X, Huang X, Yu C, Deng H, Wang Y, Zhang Z, Qiao S, Lu G, Zhao D (2006) The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 27:3396-3403
18. Wu C, Fan W, Gelinsky M, Xiao Y, Simon P, Schulze R, Doert T, Luo Y, Cuniberti G (2011) Bioactive SrO-SiO2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties. Acta Biomater 7:1797-1806
19. Saravanapavan P, Hench LL (2001) Low-temperature synthesis, structure, and bioactivity of gel-derived glasses in the binary CaO-SiO2 system. J Biomed Mater Res 54:608-618 (Pubitemid 32041826)
20. Wu C, Chang J, Xiao Y (2011) Mesoporous bioactive glasses as drug delivery and bone tissue regeneration platforms. Ther Deliv 2:1189-1198
21. Zhang Y, Cheng N, Miron R, Shi B, Cheng X (2012) Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials 33:6698-6708
22. Wu C, Zhou Y, Lin C, Chang J, Xiao Y (2012) Strontium-containing mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering. Acta Biomater 8:3805-3815
23. Zhang Y, Wei L, Chang J, Miron RJ, Shi B, Yi S, Wu C (2013) Strontium-incorporated mesoporous bioactive glass scaffolds stimulating in vitro proliferation and differentiation of bone marrow stromal cells and in vivo regeneration of osteoporotic bone defects. J Mater Chem B 1:5711-5722
24. Cheng N, Dai J, Cheng X, Li S, Miron RJ, Wu T, Chen W, Zhang Y, Shi B (2013) Porous CaP/silk composite scaffolds to repair femur defects in an osteoporotic model. J Mater Sci Mater Med 24:1963-1975
25. Miron RJ, Wei L, Bosshardt DD, Buser D, Sculean A, Zhang Y (2013) Effects of enamel matrix proteins in combination with a bovine-derived natural bone mineral for the repair of bone defects. Clin Oral Investig
26. Wei L, Miron RJ, Shi B, Zhang Y (2013) Osteoinductive and osteopromotive variability among different demineralized bone allografts. Clin Implant Dent Relat Res. doi:10.1111/cid.12118
27. Alt V, Thormann U, Ray S et al (2013) A new metaphyseal bone defect model in osteoporotic rats to study biomaterials for the enhancement of bone healing in osteoporotic fractures. Acta Biomater 9:7035-7042
28. Canettieri AC, Colombo CE, Chin CM, Faig-Leite H (2009) Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite. Int J Exp Pathol 90:520-526
29. Miron RJ, Zhang YF (2012) Osteoinduction: a review of old concepts with new standards. J Dent Res 91:736-744
30. Barrere F, van Blitterswijk CA, de Groot K (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine 1:317-332
31. Yu J, Li K, Zheng X, He D, Ye X, Wang M (2013) In vitro and in vivo evaluation of zinc-modified ca-si-based ceramic coating for bone implants. PLoS One 8:e57564
32. Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM, Amling M (2004) Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 25:3963-3972 (Pubitemid 38388562)
33. Haynes DR, Crotti TN, Zreiqat H (2004) Regulation of osteoclast activity in peri-implant tissues. Biomaterials 25:4877-4885 (Pubitemid 38520818)